
Thryve is a health technology startup focused on providing solutions for insurers, digital health platforms, remote care, and clinical trials. They offer a Wearable API that facilitates the integration of real-world evidence related to heart health, cancer, and diabetes, enabling better treatment and prevention strategies. Their services aim to enhance healthcare delivery through data-driven insights and innovative technology.
Visit WebsiteBerlin, Germany
PANTOhealth specializes in AI-powered solutions for overhead line management, focusing on real-time monitoring, predictive maintenance, and cost-effective optimizations to enhance infrastructure reliability. Their offerings include consultancy services, a comprehensive maintenance dashboard, and simulation tools aimed at improving system performance and resource allocation in rail infrastructure.
Dermanostic is a digital healthcare startup that offers online dermatological consultations, allowing users to receive treatment from qualified specialists without the need for an appointment. Patients can upload photos of their skin condition, answer a few questions, and receive a diagnosis, treatment plan, and prescription within minutes. The platform focuses on various skin issues, including acne, eczema, and hair loss, providing convenient follow-up care as well.
Zana Technology GmbH focuses on revolutionizing healthcare through the use of voice biomarker technology. Their platform analyzes voice patterns to provide insights into health conditions, particularly in cardiology and respiratory diseases, enabling proactive care, remote monitoring, and improved clinical research. Zana's solutions cater to healthcare providers, pharmaceutical companies, and MedTech firms, enhancing patient monitoring and treatment efficacy.
Aisencia is a startup focused on transforming skin pathology through advanced artificial intelligence. Their offerings include optimizing workflows for faster, more accurate, and accessible diagnoses in dermatopathology, collaborating closely with leading pathologists to meet current and future diagnostic needs.